Dave Fallace

Attributable venture investments at Alaska Permanent Fund include Juno Therapeutics. Attributable venture investments while at GF Private Equity Group include: Ahura (Acquired by Thermo Fisher Scientific Inc.), Teknovus (Acquired by Broadcom), Redline Communications (IPO), Kotura (Acquired by Mellanox), Veralight, Pathscale (Acquired by QLogic), Teros (Acquired by Citrx), Impinj, Applied Wave Research (Acquired by National Instruments), Venda and Pixtronix (Acquired by Qualcomm).